{"disease":{"id":"hpv-related-carcinoma","name":"hpv related carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05996783","title":"Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":48000,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT04679675","title":"Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":32771,"lead_sponsor_name":"Kaiser Permanente","has_results":true},{"nct_id":"NCT06465914","title":"A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9000,"lead_sponsor_name":"Shanghai Bovax Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT05247853","title":"HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV","phase":"","overall_status":"COMPLETED","enrollment_count":3127,"lead_sponsor_name":"Montefiore Medical Center","has_results":false},{"nct_id":"NCT03105856","title":"FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"Instituto Nacional de Salud Publica, Mexico","has_results":false},{"nct_id":"NCT05812027","title":"A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1150,"lead_sponsor_name":"TScan Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05973487","title":"A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":840,"lead_sponsor_name":"TScan Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03493542","title":"A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":766,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03475953","title":"A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":747,"lead_sponsor_name":"Institut Bergonié","has_results":false},{"nct_id":"NCT04970394","title":"An Observational Study of GP Verbal Reminders Upon Cervical Screening","phase":"","overall_status":"COMPLETED","enrollment_count":724,"lead_sponsor_name":"Dr. Faizan Awan","has_results":false},{"nct_id":"NCT03888599","title":"Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"University Hospital, Geneva","has_results":false},{"nct_id":"NCT05783167","title":"Self-collected Vaginal and Urine Samples in HIV-positive Women","phase":"","overall_status":"COMPLETED","enrollment_count":502,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT04436133","title":"Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":480,"lead_sponsor_name":"National Vaccine and Serum Institute, China","has_results":false},{"nct_id":"NCT05541016","title":"De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":455,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05075993","title":"Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":352,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04530201","title":"CASUS: Validation for Detection of Precursor Lesions","phase":"NA","overall_status":"COMPLETED","enrollment_count":332,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT06756269","title":"To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":330,"lead_sponsor_name":"Shanghai Bovax Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT03337269","title":"Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake","phase":"NA","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT04380623","title":"A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families","phase":"NA","overall_status":"UNKNOWN","enrollment_count":244,"lead_sponsor_name":"Meharry Medical College","has_results":false},{"nct_id":"NCT03895866","title":"Persistent Cervical HPV Infection With Clearance and Vaginal Microbiota","phase":"","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT04180215","title":"A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":198,"lead_sponsor_name":"Hookipa Biotech GmbH","has_results":false},{"nct_id":"NCT04900623","title":"Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":145,"lead_sponsor_name":"Jonathan Schoenfeld, MD, MPH","has_results":false},{"nct_id":"NCT06702033","title":"The Minimalist Trial-2","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":142,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT03749720","title":"HPV in Blood Samples From Cervical Cancer Patients.","phase":"NA","overall_status":"COMPLETED","enrollment_count":141,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT03749707","title":"HPV in Sentinel Lymph Nodes of Cervical Cancer Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06339684","title":"HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT03061435","title":"Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.","phase":"NA","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"Dr. Danielle Vicus","has_results":false},{"nct_id":"NCT06321627","title":"Radiosensitivity of HPV-related Tumors: Towards a Genomic Approach","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"European Institute of Oncology","has_results":false},{"nct_id":"NCT06598176","title":"Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT03033550","title":"Integrating Primary & Secondary Interventions for Cervical Cancer Prevention in Primary Care Settings","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Boston Medical Center","has_results":false},{"nct_id":"NCT06949800","title":"CASCADE 2002: PROTECT Study, \"PRObiotics to TrEat Anal preCancer Trial","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04083196","title":"A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"National Vaccine and Serum Institute, China","has_results":false},{"nct_id":"NCT04966481","title":"Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":81,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT03978689","title":"A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Cue Biopharma","has_results":false},{"nct_id":"NCT06454175","title":"A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":72,"lead_sponsor_name":"Shanghai Bovax Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT03107182","title":"Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"University of Chicago","has_results":true},{"nct_id":"NCT03621696","title":"Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: \"The Minimalist Trial (MINT)\"","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":63,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT04979000","title":"HPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral Risk Factors","phase":"","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT06157151","title":"PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"Precigen, Inc","has_results":false},{"nct_id":"NCT06052033","title":"Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"First Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT05996796","title":"Dry Run of the ScreenUrSelf Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT05582590","title":"Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":36,"lead_sponsor_name":"NexImmune Inc.","has_results":false},{"nct_id":"NCT03944915","title":"De-Escalation Therapy for Human Papillomavirus Negative Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"University of Chicago","has_results":true},{"nct_id":"NCT05307939","title":"A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT06636734","title":"Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":28,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT04480866","title":"CASUS: Improved and Quality Assured Collection of First-void Urine","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT06508138","title":"Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection","phase":"PHASE1","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":24,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT05061940","title":"This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.","phase":"","overall_status":"TERMINATED","enrollment_count":22,"lead_sponsor_name":"Repertoire Immune Medicines","has_results":false},{"nct_id":"NCT05686226","title":"E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Christian Hinrichs","has_results":false},{"nct_id":"NCT05232851","title":"A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Mayo Clinic","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}